2024 Q1 Form 10-K Financial Statement

#000182912624001904 Filed on March 26, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $4.559M $23.32M
YoY Change 378.45%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $907.5K $2.905M
YoY Change 234.76%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $3.351M $11.05M
YoY Change 292.44% 5812.64%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax $16.33K
% Of Pretax Income
Net Earnings -$3.827M -$11.04M
YoY Change 33.96% 395.09%
Net Earnings / Revenue -83.95% -47.34%
Basic Earnings Per Share -$0.46 -$1.33
Diluted Earnings Per Share -$0.46 -$1.33
COMMON SHARES
Basic Shares Outstanding 8.000M shares 8.300M shares 8.328M shares
Diluted Shares Outstanding 8.290M shares 8.328M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $4.095M $6.726M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $9.628M $9.737M
YoY Change -24.9% -25.1%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $141.9M $145.5M
YoY Change -4.93% 5.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $105.5M $104.0M
YoY Change 7.12% 24.44%
SHAREHOLDERS EQUITY
Retained Earnings -$42.75M -$38.92M
YoY Change 39.07% 39.6%
Common Stock $82.84K $83.06K
YoY Change -0.98% -1.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $26.72M $30.77M
YoY Change
Total Liabilities & Shareholders Equity $141.9M $145.5M
YoY Change -4.93% 5.21%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$3.827M -$11.04M
YoY Change 33.96% 395.09%
Depreciation, Depletion And Amortization $907.5K $2.905M
YoY Change 234.76%
Cash From Operating Activities -$2.158M -$4.757M
YoY Change -181.42% 74.81%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$351.0K -$10.84M
YoY Change -95.51% -75.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $873.2K
YoY Change 28.69%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$122.5K $13.82M
YoY Change -101.4% -69.23%
NET CHANGE
Cash From Operating Activities -$2.158M -$4.757M
Cash From Investing Activities -$351.0K -$10.84M
Cash From Financing Activities -$122.5K $13.82M
Net Change In Cash -$2.632M -$1.773M
YoY Change -173.64% -34.16%
FREE CASH FLOW
Cash From Operating Activities -$2.158M -$4.757M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001619312
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
114614484 usd
CY2023Q4 lrit Investment Property Gross
InvestmentPropertyGross
129508468 usd
CY2022Q4 lrit Investment Property Gross
InvestmentPropertyGross
114614484 usd
CY2022Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
usd
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
usd
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022 us-gaap Revenues
Revenues
usd
CY2022 lrit Hotel Operating Expenses
HotelOperatingExpenses
usd
CY2022 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
usd
CY2022 us-gaap Other Noncash Expense
OtherNoncashExpense
usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
usd
CY2022 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
usd
CY2022 lrit Distributions From Unconcolidated Affiliated Real Estate Entities
DistributionsFromUnconcolidatedAffiliatedRealEstateEntities
usd
CY2023 lrit Distributions Paid To Noncontrolling Interests
DistributionsPaidToNoncontrollingInterests
usd
CY2022 us-gaap Management Fee Expense
ManagementFeeExpense
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-55773
CY2023 dei Entity Registrant Name
EntityRegistrantName
LIGHTSTONE VALUE PLUS REIT IV, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-1796830
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
1985 Cedar Bridge Avenue
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Lakewood
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
08701
CY2023 dei City Area Code
CityAreaCode
732
CY2023 dei Local Phone Number
LocalPhoneNumber
367-0129
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
0 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8000000.0 shares
CY2023 dei Auditor Name
AuditorName
EisnerAmper LLP
CY2023 dei Auditor Location
AuditorLocation
New Jersey
CY2023Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
35845388 usd
CY2023Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
82935141 usd
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
10457932 usd
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
270007 usd
CY2023Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
2905386 usd
CY2023Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
126603082 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
114614484 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
9736742 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
12998999 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6726475 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8289394 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1005344 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1215200 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
1399872 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
1154466 usd
CY2023Q4 us-gaap Assets
Assets
145471515 usd
CY2022Q4 us-gaap Assets
Assets
138272543 usd
CY2023Q4 lrit Mortgage Payable Net
MortgagePayableNet
83666224 usd
CY2022Q4 lrit Mortgage Payable Net
MortgagePayableNet
63631383 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
6333078 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
6126029 usd
CY2023Q4 us-gaap Subordinated Debt Current
SubordinatedDebtCurrent
14012553 usd
CY2022Q4 us-gaap Subordinated Debt Current
SubordinatedDebtCurrent
13825600 usd
CY2023Q4 us-gaap Liabilities
Liabilities
104011855 usd
CY2022Q4 us-gaap Liabilities
Liabilities
83583012 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000.0 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000.0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000.0 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000.0 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8300000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8300000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8400000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8400000 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
83064 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
83984 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
69607889 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
70480206 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38921944 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27881782 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
30769009 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
42682408 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
10690651 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
12007123 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
41459660 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
54689531 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
145471515 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
138272543 usd
CY2023 us-gaap Revenues
Revenues
23322329 usd
CY2023 lrit Hotel Operating Expenses
HotelOperatingExpenses
18819882 usd
CY2023 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
74162 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1656075 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
689384 usd
CY2022 us-gaap Pre Opening Costs
PreOpeningCosts
1504568 usd
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
25794923 usd
CY2023 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
214225 usd
CY2022 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
90900 usd
CY2023 us-gaap Interest Expense
InterestExpense
11053923 usd
CY2022 us-gaap Interest Expense
InterestExpense
186954 usd
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-670619 usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-318052 usd
CY2023 us-gaap Other Noncash Expense
OtherNoncashExpense
17952 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-14000863 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-2608058 usd
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
-2960701 usd
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
-378122 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-11040162 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2229936 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.33
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.33
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8327650 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8327650 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8418997 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8418997 shares
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
57811336 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-2608058 usd
CY2022 lrit Distribution Paid To Noncontrolling Interests
DistributionPaidToNoncontrollingInterests
-128452 usd
CY2022 lrit Contributions Of Noncontrolling Interests
ContributionsOfNoncontrollingInterests
293270 usd
CY2022 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
678565 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
54689531 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-14000863 usd
CY2023 lrit Contributions Of Noncontrolling Interests
ContributionsOfNoncontrollingInterests
1644229 usd
CY2023 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-873237 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-14000863 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-2608058 usd
CY2023 lrit Loss From Investment In Unconsolidated Affiliated Real Estate Entity
LossFromInvestmentInUnconsolidatedAffiliatedRealEstateEntity
-670619 usd
CY2022 lrit Loss From Investment In Unconsolidated Affiliated Real Estate Entity
LossFromInvestmentInUnconsolidatedAffiliatedRealEstateEntity
-318052 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2905386 usd
CY2023 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
1457870 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
245406 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
951253 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4267978 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
332791 usd
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
186954 usd
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
186954 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4757462 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2721514 usd
CY2023 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
13427924 usd
CY2022 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
42367024 usd
CY2023 lrit Distributions From Unconcolidated Affiliated Real Estate Entities
DistributionsFromUnconcolidatedAffiliatedRealEstateEntities
-2966637 usd
CY2023 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
374999 usd
CY2022 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
2523967 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10836286 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-44890991 usd
CY2023 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
13049981 usd
CY2022 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
45433727 usd
CY2022 lrit Distributions Paid To Noncontrolling Interests
DistributionsPaidToNoncontrollingInterests
-128452 usd
CY2023 lrit Contributions Of Noncontrolling Interest
ContributionsOfNoncontrollingInterest
1644229 usd
CY2022 lrit Contributions Of Noncontrolling Interest
ContributionsOfNoncontrollingInterest
293270 usd
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
873237 usd
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
678565 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13820973 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
44919980 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1772775 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2692525 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9504594 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12197119 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7731819 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9504594 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
6380635 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
2994352 usd
CY2023 lrit Capital Expenditures For Investment Property In Accounts Payable Accrued Expenses And Other Liabilities
CapitalExpendituresForInvestmentPropertyInAccountsPayableAccruedExpensesAndOtherLiabilities
270007 usd
CY2022 lrit Capital Expenditures For Investment Property In Accounts Payable Accrued Expenses And Other Liabilities
CapitalExpendituresForInvestmentPropertyInAccountsPayableAccruedExpensesAndOtherLiabilities
4330936 usd
CY2023 lrit Unpaid Interest Accrued And Capitalized As Mortgage Payable And Construction In Progress
UnpaidInterestAccruedAndCapitalizedAsMortgagePayableAndConstructionInProgress
5200887 usd
CY2022 lrit Unpaid Interest Accrued And Capitalized As Mortgage Payable And Construction In Progress
UnpaidInterestAccruedAndCapitalizedAsMortgagePayableAndConstructionInProgress
1569946 usd
CY2023 lrit Amortization Of Deferred Financing Cost Included In Construction In Progress
AmortizationOfDeferredFinancingCostIncludedInConstructionInProgress
326103 usd
CY2022 lrit Amortization Of Deferred Financing Cost Included In Construction In Progress
AmortizationOfDeferredFinancingCostIncludedInConstructionInProgress
1783974 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6726475 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8289394 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
1005344 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
1215200 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
7731819 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
9504594 usd
CY2023 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2014-09-09
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_z2Unkifxt079" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b><i><span id="xdx_869_z6Bu941AY0T9">Use of Estimates in the Preparation of Financial Statements</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (“GAAP”). GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses during a reporting period. The most significant assumptions and estimates relate to the valuation of real estate and investments in other real estate entities. Application of these assumptions requires the exercise of judgment as to future uncertainties and, as a result, actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2023Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2022Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zzdX83nJHic1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b><i><span id="xdx_868_zsoV6LAICO43">Concentration of Risk</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">As of December 31, 2023 and 2022, the Company had cash deposited in certain financial institutions in excess of U.S. federally insured levels. The Company regularly monitors the financial stability of these financial institutions and believes that it is not exposed to any significant credit risk with respect to its cash and cash equivalents or restricted cash.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2023Q4 us-gaap Construction Loan
ConstructionLoan
83800000 usd
CY2023 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
6900000 usd
CY2023 lrit Deferred Financing Fees
DeferredFinancingFees
100000 usd
CY2022Q4 us-gaap Construction Loan
ConstructionLoan
65600000 usd
CY2022 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1700000 usd
CY2022 lrit Deferred Financing Fees
DeferredFinancingFees
2000000.0 usd
CY2023 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.1446 pure
CY2023 us-gaap Loan Processing Fee
LoanProcessingFee
3700000 usd
CY2022 us-gaap Loan Processing Fee
LoanProcessingFee
3700000 usd
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
0 usd
CY2022Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
0 usd
CY2023 lrit Repurchasement Of Common Shares
RepurchasementOfCommonShares
91999 shares
CY2023Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
9.49
CY2022 lrit Repurchasement Of Common Shares
RepurchasementOfCommonShares
79324 shares
CY2022Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
8.55
CY2023 us-gaap Leasing Commissions Expense
LeasingCommissionsExpense
573223000 usd
CY2022 us-gaap Leasing Commissions Expense
LeasingCommissionsExpense
1757949000 usd
CY2023 us-gaap Management Fee Expense
ManagementFeeExpense
763229000 usd
CY2023 lrit Total
Total
1336452000 usd
CY2022 lrit Total
Total
1757949000 usd
CY2023Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
463876 usd
CY2022Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
118030 usd
CY2016Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10.00
CY2016Q1 lrit Net Investment Annual Return
NetInvestmentAnnualReturn
0.080 pure
CY2016Q1 lrit Additional Cummulative Net Investment Rate
AdditionalCummulativeNetInvestmentRate
0.080 pure
CY2016Q1 lrit Additional Distributions Rate
AdditionalDistributionsRate
0.850 pure
CY2016Q1 lrit Aggregate Amount Rate
AggregateAmountRate
0.150 pure
CY2016Q1 lrit Pretax Noncompounded Annual Return
PretaxNoncompoundedAnnualReturn
0.080 pure
CY2023Q4 lrit Unamortized Balance
UnamortizedBalance
2900000 usd
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 dei Auditor Firm
AuditorFirmId
274

Files In Submission

Name View Source Status
0001829126-24-001904-index-headers.html Edgar Link pending
0001829126-24-001904-index.html Edgar Link pending
0001829126-24-001904.txt Edgar Link pending
0001829126-24-001904-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lightstonereit4_10k.htm Edgar Link pending
lightstonereit4_ex21.htm Edgar Link pending
lightstonereit4_ex31-1.htm Edgar Link pending
lightstonereit4_ex31-2.htm Edgar Link pending
lightstonereit4_ex32-1.htm Edgar Link pending
lightstonereit4_ex32-2.htm Edgar Link pending
lrit-20231231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lrit-20231231_cal.xml Edgar Link unprocessable
lrit-20231231_def.xml Edgar Link unprocessable
lrit-20231231_lab.xml Edgar Link unprocessable
lightstonereit4_10k_htm.xml Edgar Link completed
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
lrit-20231231_pre.xml Edgar Link unprocessable